Denali Therapeutics Inc. (DNLI)
Denali Therapeutics Statistics
Share Statistics
Denali Therapeutics has 145.28M shares outstanding. The number of shares has increased by 1.83% in one year.
| 145.28M |
| 1.83% |
| 0.9% |
| 75.51% |
| n/a |
| 2,261 |
| 0.15% |
Short Selling Information
The latest short interest is 12.1M, so 8.33% of the outstanding shares have been sold short.
| 12.1M |
| 8.33% |
| 9.33% |
| 9.15 |
Valuation Ratios
The PE ratio is -7.93 and the forward PE ratio is -5.27. Denali Therapeutics's PEG ratio is -0.06.
| -7.93 |
| -5.27 |
| 0 |
| 2.9 |
| 2.73 |
| -9.22 |
| -0.06 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Denali Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 8.46, with a Debt / Equity ratio of 0.04.
| 8.46 |
| 8.46 |
| 0.04 |
| -0.12 |
| -0.13 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-954,340.86 |
| 443 |
| 0 |
| n/a |
Taxes
| 68K |
| -0.02% |
Stock Price Statistics
The stock price has increased by -33.32% in the last 52 weeks. The beta is 1.33, so Denali Therapeutics's price volatility has been higher than the market average.
| 1.33 |
| -33.32% |
| 13.96 |
| 21.22 |
| 51.4 |
| 1,481,968 |
Balance Sheet
The company has 174.96M in cash and 48.71M in debt, giving a net cash position of 126.25M.
| 174.96M |
| 48.71M |
| 126.25M |
| -1.54B |
| 1.27B |
| 786.76M |
Cash Flow
In the last 12 months, operating cash flow was -347.69M and capital expenditures -15.91M, giving a free cash flow of -363.61M.
| -347.69M |
| -15.91M |
| -363.61M |
| -2.21 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
DNLI does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for DNLI is $32.5, which is 128.7% higher than the current price. The consensus rating is "Buy".
| $32.5 |
| 128.7% |
| Buy |
| 16 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 5.21 |
| 2 |